CD11c regulates hematopoietic stem and progenitor cells under stress

Area of Science:

• Immunology
• Hematology
• Cell Biology

Background:

• Beta-2 integrins (CD11a-d) are key leukocyte adhesion molecules.
• Research has primarily focused on CD11a and CD11b, with CD11c's function less characterized.
• CD11c is known as a dendritic cell marker but its role in other cell types is limited.

Purpose of the Study:

• To investigate the expression and function of CD11c in hematopoietic stem and progenitor cells (HSPCs).
• To determine the role of CD11c in HSPC regulation, particularly under stress conditions.
• To elucidate the impact of CD11c deficiency on HSPC survival and expansion.

Main Methods:

• Analysis of CD11c expression on hematopoietic stem and progenitor cells (HSPCs).
• Phenotypic characterization of HSPCs in CD11c knockout mice under normal conditions.
• Assessment of HSPC numbers and apoptosis in CD11c deficient mice during sepsis and bone marrow transplantation models.

Main Results:

• CD11c is expressed on short-term HSPCs and multipotent progenitor cells.
• CD11c deficiency did not impact HSPC numbers in healthy mice.
• CD11c deficiency led to increased apoptosis and significant loss of HSPCs in sepsis and bone marrow transplantation models.

Conclusions:

• CD11c plays a distinct role in regulating HSPC expansion under stress, unlike other beta-2 integrins.
• CD11c is expressed on HSPCs and functions as a critical regulator of their survival during stress.
• CD11c deficiency results in HSPC loss through apoptosis in conditions like sepsis and bone marrow transplantation.